Preferred Name |
Cycloserine |
|
Synonyms |
D-cycloserine Cycloserine (+)-4-Amino-3-isoxazolidinone D-Cycloserine CYCLOSERINE 3-Isoxazolidinone, 4-amino-, d- Oxamycin Seromycin Tisomycin |
|
Definitions |
An analogue of the amino acid D-alanine with broad-spectrum antibiotic and glycinergic activities. D-cycloserine interferes with bacterial cell wall synthesis by competitively inhibiting two enzymes, L-alanine racemase and D-alanine:D-alanine ligase, thereby impairing peptidoglycan formation necessary for bacterial cell wall synthesis. This agent may be bactericidal or bacteriostatic, depending on its concentration at the infection site and the susceptibility of the organism. In addition, D-cycloserine is an excitatory amino acid and partial agonist at the glycine binding site of the NMDA receptor in the central nervous system (CNS); binding to the central NMDA receptor may result in amelioration of neuropathic pain. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47466 |
|
ALT_DEFINITION |
A drug used to treat tuberculosis. It is also being studied in the treatment of pain and nerve problems (numbness, tingling) caused by chemotherapy and in the treatment of low back pain, autism, certain anxiety disorders, and schizophrenia. D-cycloserine is a type of antibiotic. |
|
CAS_Registry |
68-41-7 |
|
CHEBI_ID |
CHEBI:40009 |
|
Chemical_Formula |
C3H6N2O2 |
|
code |
C47466 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
An analogue of the amino acid D-alanine with broad-spectrum antibiotic and glycinergic activities. D-cycloserine interferes with bacterial cell wall synthesis by competitively inhibiting two enzymes, L-alanine racemase and D-alanine:D-alanine ligase, thereby impairing peptidoglycan formation necessary for bacterial cell wall synthesis. This agent may be bactericidal or bacteriostatic, depending on its concentration at the infection site and the susceptibility of the organism. In addition, D-cycloserine is an excitatory amino acid and partial agonist at the glycine binding site of the NMDA receptor in the central nervous system (CNS); binding to the central NMDA receptor may result in amelioration of neuropathic pain. |
|
FDA_UNII_Code |
95IK5KI84Z |
|
FULL_SYN |
D-cycloserine Cycloserine (+)-4-Amino-3-isoxazolidinone D-Cycloserine CYCLOSERINE 3-Isoxazolidinone, 4-amino-, d- Oxamycin Seromycin Tisomycin |
|
label |
Cycloserine |
|
Legacy Concept Name |
Cycloserine |
|
NCI_Drug_Dictionary_ID |
469006 |
|
NSC Number |
154851 |
|
PDQ_Closed_Trial_Search_ID |
469006 |
|
PDQ_Open_Trial_Search_ID |
469006 |
|
Preferred_Name |
Cycloserine |
|
prefixIRI |
Thesaurus:C47466 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0010590 |
|
subClassOf |